Neuropeptide Y levels, when compared to control, were not significantly increased on ELISA analysis in DLB by (p = 0.22, uncorrected) and in AD NPY was increased by approximately 20 % compared to control (p = 0.027, uncorrected) (see Table 2). Here, NPY is linked to Alzheimer disease.